- Filed
- Jun 30, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jun 27, 2025 | 2.67M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 2.64M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 2.58M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | $282K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$2.6M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $329K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $381K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$24.68M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$21.3M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $6.08M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $13.45M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $31.06M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $28.77M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $31.86M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $29.3M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.96M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.69M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $7.17M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $8.01M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$1.24 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$3.62 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$1.24 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$3.62 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $2.25M |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $6.19M |
| Rd Expense | Q1 2025 · Mar 31, 2025 | $356K |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $1.42M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$3.27M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$9.36M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$2.94M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$4.37M |
| Gross Profit | Q1 2025 · Mar 31, 2025 | −$180K |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $2.26M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $312K |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $477K |
| Revenue | Q1 2025 · Mar 31, 2025 | $132K |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $2.74M |